IgE antibody-specific activity in human allergic disease

Immunologic Research

Volumn 47, Issue 1-3, 2010, Pages 273-284

  Hamilton, Robert G ^a,b   MacGlashan Jr , Donald W ^a   Saini, Sarbjit S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Affinity; Allergy; Clonality; Concentration; Human; IgE; Specific activity; Specific IgE to total IgE ratio

Indexed keywords

ALLERGEN; EPITOPE; HISTAMINE; HYMENOPTERA VENOM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INSULIN; OMALIZUMAB; PENICILLIN G; PLACEBO; ANTIIDIOTYPIC ANTIBODY; ARTHROPOD VENOM; MONOCLONAL ANTIBODY;

AGE DISTRIBUTION; ALLERGIC DISEASE; ALLERGY; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; BASOPHIL; BLOOD SAMPLING; CELL LOSS; CLINICAL TRIAL; DISEASE COURSE; DOMESTIC ANIMAL ALLERGY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EFFECTOR CELL; FOOD ALLERGY; HISTAMINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MEDIATOR; MILK; MILK ALLERGY; PEANUT; PEANUT ALLERGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; REVIEW; SENSITIZATION; SEROLOGY; SYMPTOM; ANIMAL; BLOOD; CAT; CLINICAL TRIAL (TOPIC); HYMENOPTERA; HYPERSENSITIVITY; IMMUNOLOGY;

ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ARACHIS HYPOGAEA; ARTHROPOD VENOMS; BASOPHILS; CATS; CLINICAL TRIALS AS TOPIC; HISTAMINE RELEASE; HUMANS; HYMENOPTERA; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MILK; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED;

EID: 77953961017     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-009-8160-3     Document Type: Review

References (18)

1. K Ishizaka T Ishizaka 1966 Physiochemical properties of reaginic antibody I. Association of reaginic activity with an immunoglobulin other than gamma A or gamma G globulin J Allergy 37 336 349 10.1016/0021-8707(66)90133-X 1:CAS:528:DyaF28Xktlams74%3D 4161346
2. SGO Johansson H Bennich 1967 Immunological studies of an atypical (myeloma) immunoglobulin Immunology 13 381 394 1:CAS:528:DyaF1cXitVGgtA%3D%3D 4168094
3. SA Walker PG Riches G Wild AM Ward PJ Shaw S Desai JR Hobbs 1986 Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation Clin Exp Immunol 66 633 639 1:STN:280: DyaL2s7ovVCnsw%3D%3D 2436842
4. B Burrows FD Martinez M Halonen RA Barbee MG Cline 1989 Association of asthma with serum IgE levels and skin test reactivity to allergens N Eng J Med 320 271 277 1:STN:280:DyaL1M%2FpslWnug%3D%3D
5. MR Sears B Burrows EM Flannery GP Herbison CJ Hewitt MD Holdaway 1991 Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children N Engl J Med 325 1067 1071 1:STN:280: DyaK3MzmslaisA%3D%3D 1891008
6. Hamilton RG. Assessment of human allergic diseases. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM, editors. Clinical immunology: principles and practice, 3rd ed, Chap. 100. London: Mosby Elsevier Ltd; 2008. p. 1471-84.
7. Hamilton RG. Proficiency survey-based evaluation of clinical total and allergen-specific IgE assay performance. Arch Path Lab Med. 2010;134 (in press).
8. LH Christensen J Holm G Lund E Riise K Lund 2008 Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge J Allergy Clin Immunol 122 298 304 10.1016/j.jaci.2008.05.026 1:CAS:528:DC%2BD1cXpsVGgsL4%3D 18572230
9. Matsson PNJ, Hamilton RG, Homburger HA, Esch RE, et al. Analytical performance characteristics and clinical utility of immunological assays for human IgE antibodies of defined allergen specificities. 2nd ed. Wayne, PA: Clinical Laboratory Standards Institute; 2008.
10. ST Holgate AG Chuchalin J Hebert J Lotvall BG Persson KF Chung, et al. 2004 Efficacy and safety of a recombinant anti-IgE antibody (omalizumab) in severe allergic asthma Clin Exp Allergy 34 632 638 10.1111/j.1365-2222.2004. 1916.x 1:CAS:528:DC%2BD2cXkt12ju78%3D 15080818 (Pubitemid 38534897)
11. R) treatment Allergy 64 1472 1477 10.1111/j.1398-9995.2009.02051.x 1:CAS:528:DC%2BD1MXhtlSktL%2FF 19393000
12. A Kober H Perborn 2006 Quantitation of mouse-human chimeric allergen-specific IgE antibodies with ImmunoCAP technology J Allergy Clin Immunol 117 S219 10.1016/j.jaci.2005.12.865 (Abstract 845)
13. J Ker TV Hartert 2009 The atopic march: what's the evidence? Ann Allergy Asthma Immunol 103 282 289 10.1016/S1081-1206(10)60526-1 19852191
14. RA Barbee M Halonen W Kaltenborn M Lebowitz B Burrows 1987 A longitudinal study of serum IgE in a community cohort: correlations with age, sex, smoking, and atopic status J Allergy Clin Immunol 79 919 927 10.1016/0091-6749(87)90241-7 1:STN:280:DyaL2s3itlKitA%3D%3D 3584747 (Pubitemid 17085585)
15. Holgate ST. Implications for clinical practice in anti-IgE therapy. A new era in the control of severe persistent allergic asthma. Copenhagen: European Respiratory Society Congress; 2005.
16. SGO Johansson H Oman A Nopp S Petterson 2006 Importance of IgE antibody levels in anti-IgE treatment Allergy 61 1216 1219 10.1111/j.1398-9995.2006. 01172.x 1:CAS:528:DC%2BD28XhtF2gs7bI 16942572 (Pubitemid 44326359)
17. Eckman JA, Sterba PM, Kelly D, Alexander V, Bochner BS, MacGlashan DW, Jr, Saini SS. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol. 2010;125 (in press).
18. RG Hamilton H Saito 2008 IgE antibody concentration, specific activity, clonality, and affinity measures from future diagnostic confirmatory tests J Allergy Clin Immunol 122 305 306 10.1016/j.jaci.2008.05.009 18571709